1. Home
  2. CLW vs ARMP Comparison

CLW vs ARMP Comparison

Compare CLW & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

N/A

Current Price

$14.43

Market Cap

213.2M

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$3.72

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLW
ARMP
Founded
1926
N/A
Country
United States
United States
Employees
3710
N/A
Industry
Paper
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.2M
199.7M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
CLW
ARMP
Price
$14.43
$3.72
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
★ $20.00
$17.50
AVG Volume (30 Days)
★ 269.7K
75.1K
Earning Date
10-26-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $1,555,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.30
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.42
N/A
52 Week Low
$11.73
$2.75
52 Week High
$23.59
$14.98

Technical Indicators

Market Signals
Indicator
CLW
ARMP
Relative Strength Index (RSI) 39.88 55.78
Support Level $12.21 $3.38
Resistance Level $14.56 $3.96
Average True Range (ATR) 0.97 0.36
MACD 0.14 0.11
Stochastic Oscillator 43.93 93.64

Price Performance

Historical Comparison
CLW
ARMP

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: